MDDR contains over 150,000 biologically relevant compounds and well-defined derivatives. Updates add about 10,000 substances a year to the database. MDDR, jointly produced by BIOVIA and Thomson Reuters, covers patent literature, journals, meetings, and congresses.
Medicinal chemists, pharmacologists, and molecular modelers use the database to create SAR tables (matching chemical structure to pharmacological effect) and find competitive information about compounds similar to their lead compounds.
MDDR provides:
Chemical structure
Calculated properties based on chemical structure
3D models (calculated with Corina)
Compound name – trademarks and company codes
CAS registry number
Biological activity based on the Prous classification system
Description of therapeutic action containing ED50, LD50, inhibition values, etc.
Patent information including patent number, title, source, priority number and inventors’ names
Literature references hyperlinked to primary literature (full text, abstracts, patents, conference proceedings, etc.)
Company codes, generic names, trade names and trademark names
Originating company
Development phase in the R&D process
Image Gallery
EnlargeView biological testing results for low toxicity antineoplastic agents in MDDR.